Pais / Región
Paises

Provincias / Departamentos
Colombia Colombia
Argentina Argentina
Canada Canada
Chile Chile
Ecuador Ecuador
España España
Guatemala Guatemala
Honduras Honduras
Mexico Mexico
Panama Panama
Paraguay Paraguay
United States United States
Uruguay Uruguay
Categorias / Industrias
Publication: 0000-00-00 00:00:00
United States SAM

Synthesis of GMP and Non-GMP Bulk Drugs Material and Analysis of Bulk Drugs & Pharmaceutical Formulations

Process Number HHS-NIH-NCI-SBSS-112021

USA

Dates:


Notice ID:

HHS-NIH-NCI-SBSS-112021

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

NIH NCI

Office:

NIH NCI

General Information:


All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

(utc-05:00) eastern standard time, new york, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

dec 06, 2021 11:30 am est

Inactive Policy:

15 days after response date

Original Inactive Date:

dec 21, 2021

Initiative:
  • None***--***

Classification:


NAICS Code:

325412 - pharmaceutical preparation manufacturing

Description:


Original Set Aside:

This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. A determination by the Government not to compete this requirement as a set-aside based upon responses to this notice is solely within the discretion of the Government. Interested parties are expected to review this notice and the attached draft Statement of Works (SOW) to familiarize themselves with the requirement of this project; failure to do so will be at your firm’s own risk. Please see the attached Small Business Sources Sought Notice and Draft SOW for details.

Attachments / Links:


Document Size Updated date Download

Contact Information:


OFFICE OF ACQUISITIONS 6011 EXECUTIVE BLVD.SUITE 501

ROCKVILLE , MD 20852

USA

Primary Point of Contacts:

Junli Collins

Secondary Point of Contact:

Andrew May